This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Do These Speculative Plays Have Room To Double?

Chris Lau, Kapitall: When a stock doubles or more, it is hard for market participants missing the initial rally to make a move. The reasons could vary, but includes fear of a stock reaching a top, pride, or an unwillingness to speculate. This is the case for companies in the solar energy space and conglomerates in Japan.

Solar Rally Continues

In the solar energy sector, Yingli Green Energy (YGE) and First Solar (FSLR) are up. Yingli is up 149% in the last six month, while First Solar is up 279% in a one year period. Yingli would be up even higher if it were not for the recent profit taking:

An urgency to cover short positions could explain the recent rally. Short float was 28% for First Solar.

In addition to Yingli raising guidance, the macroeconomic environment is improving for the solar energy sector. JA Solar (JASO) reported quarterly results that were higher than consensus. The company reported a loss due to lower PV pricing, but shipment rose 20.8% to 442.7 megawatts. JA Solar expects margins to a positive 6% in the current quarter, and reiterated that it would produce between 1.7-1.9 gigawatts in the fiscal year.

Japan’s Sony Defies Gravity

Helped by hedge fund manager Dan Loeb pushing for changes at Sony (SNE), shares have more than doubled from last October, 2012. Loeb wants Sony to maximize shareholder value. This could be accomplished by spinning off the entertainment unit or exiting the electronics business.

Sony is performing well in the smartphone market. Its Xperia line of phones, which runs on Android, is winning praise from critics, and sales are improving. On the television market, Sony plans to build 4K televisions. The problem with the TV plan is that it will take time before prices drop. 4K televisions are not yet on the mainstream market, and adoption of the expensive technology is uncertain.

Giant Pharmaceutical Company Rallies

In the Pharmaceutical space, Valeant (VRX) rose another 12.8% after rumors were made that it might buy Bausch & Lomb. On Monday, May 27, the company said it will pay $4.5 billion for the company, and another $4.2 billion in paying Bausch & Lomb debt. This makes the deal worth nearly $9 billion. The purchase will mean a $800 million reduction in costs annually for the merged companies.

Valeant is a company that has solid, disciplined management that grows by acquiring companies. Valeant shares more than doubled within the last three years:

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,776.12 -200.19 -1.11%
S&P 500 2,067.89 -18.35 -0.88%
NASDAQ 4,900.8850 -46.5560 -0.94%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs